- Home
- NCA vs BWAY Comparison
NCA vs BWAY Comparison
Compare NCA & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCA
- BWAY
- Stock Information
- Founded
- NCA 1987
- BWAY 2003
- Country
- NCA United States
- BWAY Israel
- Employees
- NCA N/A
- BWAY N/A
- Industry
- NCA Investment Managers
- BWAY Medical/Dental Instruments
- Sector
- NCA Finance
- BWAY Health Care
- Exchange
- NCA Nasdaq
- BWAY Nasdaq
- Market Cap
- NCA 280.8M
- BWAY 280.7M
- IPO Year
- NCA N/A
- BWAY 2019
- Fundamental
- Price
- NCA $8.99
- BWAY $16.81
- Analyst Decision
- NCA
- BWAY Strong Buy
- Analyst Count
- NCA 0
- BWAY 2
- Target Price
- NCA N/A
- BWAY $18.00
- AVG Volume (30 Days)
- NCA 59.6K
- BWAY 59.4K
- Earning Date
- NCA 01-01-0001
- BWAY 11-11-2025
- Dividend Yield
- NCA 3.92%
- BWAY N/A
- EPS Growth
- NCA N/A
- BWAY 679.98
- EPS
- NCA N/A
- BWAY 0.11
- Revenue
- NCA N/A
- BWAY $46,084,000.00
- Revenue This Year
- NCA N/A
- BWAY $335.63
- Revenue Next Year
- NCA N/A
- BWAY $22.10
- P/E Ratio
- NCA N/A
- BWAY $58.96
- Revenue Growth
- NCA N/A
- BWAY 26.50
- 52 Week Low
- NCA $7.77
- BWAY $7.84
- 52 Week High
- NCA $9.12
- BWAY $17.00
- Technical
- Relative Strength Index (RSI)
- NCA 58.92
- BWAY 67.88
- Support Level
- NCA $8.91
- BWAY $15.36
- Resistance Level
- NCA $9.01
- BWAY $16.34
- Average True Range (ATR)
- NCA 0.10
- BWAY 0.79
- MACD
- NCA -0.00
- BWAY 0.13
- Stochastic Oscillator
- NCA 70.51
- BWAY 99.58
About NCA Nuveen California Municipal Value Fund
Nuveen California Municipal Value Fund Inc is a diversified closed-end management investment company. Its primary objective is to provide current income exempt from regular federal and California income taxes. The fund's secondary objective is to enhance portfolio value relative to the California municipal bond market by investing in tax-exempt California municipal securities that the Fund's investment adviser and/or the Fund's sub-adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.